The movie may be fictional but the reality may not be too far behind.

What Are Nootropics?

Note that these are not comprehensive descriptions.

Hand open with two colorful pills inside

Richard Newstead / Getty Images

Those can be found in sources cited.

Nootropics are either used alone or in combination with other nootropics.

This is referred to as stacking.

Such compounds, which can be natural or synthetic, are more extensively researched than those used alone.

Not included in the list below are prescription psychostimulants, such as Adderall andRitalin.

More alarming, when taken in high doses, they have the potential to induce psychosis.

Most nootropics are not approved for use as a medical drug or dietary supplement in the U.S.

Developed in 1964, it is one of the more researched nootropics in the racetam class of supplements.

Initially developed for memory and learning, many anecdotal reports also claim that it increases creativity.

There are other anecdotal reports that the treatment is effective for children with down syndrome.

However, clinical studies show Piracetam therapy does not enhance cognitive functioning in children with down syndrome.

It also acts as a stimulant, increasing mental energy, alertness, and motivation.

Its cognitive benefits including increasing learning ability and memory acquisition, and accelerating neural development.

But there are limitations.

All the more reason to consult with a medical professional before using.

Psychotherapy has been shown to induce structural changes in the brain.

Other interventions that positively influence neuroplasticity include meditation, mindfulness, and compassion.

Exercise and nutrition also play an important role in neuroplasticity.

Many vitamins and ingredients found naturally in food products have been shown to have cognitive-enhancing effects.

2004;82(3):483-506, table of contents.

2001;155(4):442-8. doi:10.1001/archpedi.155.4.442

Moyer MW.A Safe Drug to Boost Brainpower.Scientific American.

Compound Summary: Ginsenoside RG1.

U.S. National Library of Medicine.

2017;41:S877-S878.

doi:10.1016/j.eurpsy.2017.01.1769

Froestl W, Muhs A, Pfeifer A.Cognitive enhancers (nootropics).

Part 2: drugs interacting with enzymes.J Alzheimers Dis.

2013;33(3):547-658. doi:10.3233/JAD-2012-121537